Literature DB >> 10872613

Late results of acute medial necrosis in rabbit aorta.

M Nakamura1, M Tanaka, M Oumi, T Yamamoto, T Higo, T Yamawaki, K Miyata.   

Abstract

To clarify whether acute medial necrosis of the aorta induces aneurysms and intimal thickening at a later stage, we first attempted to induce acute aortic medial necrosis in 47 normal rabbits by the administration of Russell's viper venom intraperitoneally and of angiotensin II intravenously as used in a previous study and then followed the rabbits for 1 and 2 months respectively. As a control, 18 adult normal rabbits were used. Six control and 20 treated rabbits were sacrificed after aortagraphy at the end of one month, while the remaining 12 control and 27 treated rabbits were sacrificed at the end of 2 months. We evaluated the aortic lesions by gross observations and both light and electron microscopic examinations. In addition, at the end of one month, aortagraphy was performed to measure the luminal diameter of the aorta of the 6 control and 20 treated rabbits. We macroscopically found the saccular lesions to be surrounded by small crater like lesions mainly at the thoracic aortas in 18 out of 47 treated rabbits. These lesions consisted of the necrosis and calcification of the aortic media and the destruction of the elastic fiber along with intimal thickening. However, no aneurysmal dilatation was found in the aortagraphy findings. We thus conclude that acute medial necrosis produced saccular and crater like lesions but these lesions were not confirmed by aortagraphy.

Entities:  

Mesh:

Year:  2000        PMID: 10872613     DOI: 10.5551/jat1994.6.42

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  1 in total

1.  Bilateral blindness following Russell's viper bite - a rare clinical presentation: a case report.

Authors:  Chandrika Jayakanthi Subasinghe; Chamara Sarathchandra; Thambyaiah Kandeepan; Aruna Kulatunga
Journal:  J Med Case Rep       Date:  2014-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.